Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands (<sup>11</sup>C-NR2B-Me enantiomers) have high binding in cerebellum but not to σ1 receptors.

导出 OA

翻译打印收藏纠错

作者： Lisheng,Cai ^[1] ; Jeih-San,Liow ^[2] ; Cheryl L,Morse ^[2] ; Sanjay,Telu ^[2] ; Riley,Davies ^[2] ; Lester S,Manly ^[2] ; Sami S,Zoghbi ^[2] ; Frederick T,Chin ^[3] ; Robert B,Innis ^[2] ; Victor W,Pike ^[2]

作者单位： Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Dr, Bldg 10, Room B3 C346, Bethesda, MD, 20892, USA. LishengCai@mail.nih.gov. ^[1] Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Dr, Bldg 10, Room B3 C346, Bethesda, MD, 20892, USA. ^[2] Molecular Imaging Program at Stanford, Department of Radiology, Stanford University, 1201 Welch Road, Rm. PS049, Stanford, CA, 94305-584, USA. ^[3]

关键词 GluN2B NMDA receptor NR2B-Me PET σ1 receptor

DOI 10.1186/s13550-023-00975-6

PMID 37017827

发布时间 2024-05-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

EJNMMI research

2023年13卷1期

28页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands (<sup>11</sup>C-NR2B-Me enantiomers) have high binding in cerebellum but not to σ1 receptors.

EJNMMI research

相似文献

EJNMMI research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Candidate 3-benzazepine-1-ol type GluN2B receptor radioligands (<sup>11</sup>C-NR2B-Me enantiomers) have high binding in cerebellum but not to σ1 receptors.

EJNMMI research

相似文献

EJNMMI research

相关期刊

检索历史清除